AI-Powered Clinical Trial Optimization
— Service Area
Digital Health & AI Infrastructure
— Focus Area
AI-Driven Clinical Trial Acceleration
— CLIENT
A leading professional services firm advising global pharma companies on AI strategy and cloud transformation.
Interested in learning more?
— Challange
The client was assisting a top pharmaceutical company in optimizing clinical trial processes using AI. The primary challenges included:
- Slow patient recruitment and retention rates due to fragmented data across multiple trial sites.
- Regulatory concerns related to patient data privacy and compliance with GxP, HIPAA, and GDPR.
- High computational costs for AI-driven trial simulations, making traditional hyperscaler cloud solutions financially unsustainable.
- Interoperability issues between AI models and existing Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), and Real-World Data (RWD) platforms.
— Approach
Our solution involved a multi-faceted AI strategy tailored for clinical trial optimization:
- Federated Learning for Secure AI Model Training
- Implemented a federated learning framework to train AI models across multiple clinical sites without centralizing sensitive patient data, ensuring compliance with HIPAA and GDPR.
- GPUaaS for Cost-Efficient AI Model Training
- Shifted AI workloads from traditional hyperscalers (AWS, Azure, GCP) to GPU-as-a-Service (GPUaaS) providers like CoreWeave and Lambda Labs, reducing AI training costs by up to 40% while improving computational performance.
- Predictive Analytics for Patient Recruitment
- Deployed AI-powered predictive analytics to analyze real-world patient data from EHRs, genomics, and wearable devices, helping identify eligible participants faster and with greater accuracy.
- MLOps & AI Governance for Regulatory Compliance
- Integrated explainability (XAI) tools such as SHAP and LIME to ensure AI-driven decisions were interpretable for regulatory audits.
- Established a continuous monitoring framework to detect AI model drift, ensuring model accuracy over time.
- Interoperability & Hybrid Cloud Deployment
- Ensured seamless integration with existing CTMS, EDC, and pharma R&D platforms, enabling real-time AI-driven insights without disrupting workflows.
- Leveraged a hybrid cloud approach, combining on-premises infrastructure for compliance-sensitive data and cloud-based AI for scalable analytics.
— Expected Results
- 30% reduction in patient recruitment time, leading to faster clinical trial completion.
- 40% cost savings on AI model training by using GPUaaS over traditional hyperscalers.
- Improved regulatory compliance through explainable AI and secure federated learning.
- Enhanced trial success rates by ensuring diverse and eligible patient participation through AI-driven analytics.
"We learn how to leverage AI-powered predictive analytics, federated learning, and cost-efficient GPUaaS solutions, to reduce patient recruitment time and lower AI compute costs for our pharma clients."
— Director, AI & Digital Transformation